Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “California”
- Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by SurgeryActive Not Recruiting
Sponsor: ECOG-ACRIN Cancer Research Group
Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7 · Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7
United States
Sponsor: Quetzal Therapeutics
Acute Promyelocytic Leukemia (APL) · Acute Promyelocytic Leukaemia · Acute Promyelocytic Leukemia With PML-RARA · Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
United States, France, Spain
Sponsor: University of California, Los Angeles
Stroke
United States
- A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular DystrophyActive Not Recruiting
Sponsor: Epicrispr Biotechnologies, Inc.
Facioscapulohumeral Muscular Dystrophy
United States, Australia, New Zealand
- Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down SyndromeActive Not Recruiting
Sponsor: Children's Oncology Group
Acute Myeloid Leukemia · Down Syndrome · Myelodysplastic Syndrome · Myeloid Leukemia Associated With Down Syndrome
United States, Australia, Canada, New Zealand, Puerto Rico +1 more
Sponsor: AstraZeneca
Chronic Kidney Disease With High Proteinuria
United States, Argentina, Australia, Austria, Brazil +25 more
Sponsor: Biogen
Immunoglobulin A Nephropathy (IgAN)
United States, Argentina, Australia, Belgium, Brazil +23 more
- Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaRecruiting
Sponsor: Alliance for Clinical Trials in Oncology
Angioimmunoblastic T-cell Lymphoma · Enteropathy-Associated T-Cell Lymphoma · Follicular T-Cell Lymphoma · Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
United States
- Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin LymphomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Recurrent Classic Hodgkin Lymphoma · Refractory Classic Hodgkin Lymphoma
United States
- Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's DiseaseActive Not Recruiting
Sponsor: University of California, Los Angeles
Mild Cognitive Impairment · Amnestic Mild Cognitive Disorder · Deep Brain Stimulation · Mild Alzheimer's Disease
United States
Sponsor: Merck Sharp & Dohme LLC
Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Neoplasms
United States, Australia, Belgium, Brazil, Canada +17 more
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Lung Non-Small Cell Squamous Carcinoma · Lung Non-Squamous Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8
United States, Guam
- Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive PatientsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
B-Cell Acute Lymphoblastic Leukemia
United States, Belgium, Canada, Denmark, France +6 more
Sponsor: AstraZeneca
Transthyretin Amyloidosis · ATTR-CM · ATTRv-PN · ATTR
United States, Canada, China, Germany, Spain +1 more
Sponsor: Novartis Pharmaceuticals
Scleroderma, Diffuse
United States, Argentina, Australia, Austria, Belgium +17 more
- A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CFActive Not Recruiting
Sponsor: ReCode Therapeutics
Cystic Fibrosis
United States, France, Netherlands, New Zealand, United Kingdom
- Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Breast Adenocarcinoma
United States, Peru, South Africa
Sponsor: Cedars-Sinai Medical Center
Takotsubo Cardiomyopathy
United States
Sponsor: UCB Biopharma SRL
Moderate to Severe Plaque Psoriasis
United States, Belgium, Canada, Czechia, Germany +5 more
- To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR MutationsActive Not Recruiting
Sponsor: AstraZeneca
Lung Cancer
United States, China, Israel, South Korea, Spain +4 more
Sponsor: Jonsson Comprehensive Cancer Center
Sleep Disorders · Sleep Initiation and Maintenance Disorders · Dyssomnias · Mental Disorders
United States
Sponsor: Vanderbilt-Ingram Cancer Center
Advanced Clear Cell Renal Cell Carcinoma · Metastatic Clear Cell Renal Cell Carcinoma · Stage III Renal Cell Cancer AJCC v8 · Stage IV Renal Cell Cancer AJCC v8
United States
- A Nurse-Led Intervention for Fear of Progression in Advanced CancerActive Not Recruiting
Sponsor: City of Hope Medical Center
Advanced Lung Carcinoma · Metastatic Malignant Female Reproductive System Neoplasm · Stage III Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8
United States
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8
United States
Sponsor: National Cancer Institute (NCI)
Malignant Glioma
United States, Australia, Canada, New Zealand